SerpApi.Org
Drug manufacturer Unique Pharmaceutical Laboratories is issuing a voluntary recall after four lots of the drug Cetirizine was cross-contaminated with the drug Ranitidine thus creating a life-threatening mix.
Cetirizine is the generic brand of Zyrtec, which treats various allergies, and Ranitidine is the generic brand for Zantac. Zantac is used to treat stomach and heartburn-related issues. The cross-contamination of the two drugs can be life-threatening if someone is allergic or hypersensitive to Ranitidine or its ingredients.
In a notice from the FDA, a person could experience a number of adverse events if they take the cross-contaminated medicine, including:
- dangerous drop in blood pressure
- shortness of breath
- trouble swallowing
- swelling of the throat or face
- widespread itchy hives
- loss of consciousness
- anaphylaxis, which can be fatal without immediate treatment
Unique Pharmaceuticals says it has not received reports of adverse events experienced by the public.
The recall refers to the Cetirizine Hydrochloride 5 mg tablets with a quantity of 100 per bottle with an expiration date of October 2028. The National Drug Code is 16571-401-10, the distributor is Rising Pharma Holdings Inc.
These are the lots recalled:
- GY825029
- GY825030
- GY825031
- GY825032
Consumers with general or medical inquiries should contact Rising Pharma Holdings Inc. at 1-844-874-7464 Monday through Friday from 8 a.m. to 5 p.m. Eastern Time or by email at [email protected] or [email protected].
Anyone experiencing problems after taking the drug should call their doctor or healthcare provider.
